| Product Name | MF | CAS | Details |
|---|
| 2-[2-(Aminomethyl)phenoxy]-N-(oxolan-2-ylmethyl)acetamide hydrochloride | C14H21ClN2O3 | 1171843-55-2 | Details |
| 6-Ethylpyrimidin-4-amine | C6H9N3 | 856160-67-3 | Details |
| Grundmanns ketone | C18H32O | 66251-18-1 | Details |
| Moexiprilat-d5 | C25H25D5N2O7 | 1356840-08-8 | Details |
| CPI17 alpha antibody | Details |
| 7-Oxo-β-sitosterol | C29H48O2 | 2034-74-4 | Details |
| Ethyl 5-amino-1-(p-tolyl)-1H-pyrazole-4-carboxylate | C13H15N3O2 | 15001-11-3 | Details |
| 1-[(2-Bromophenyl)methyl]pyrrolidin-2-one | C11H12BrNO | 756876-22-9 | Details |
| 5-(2,3-Dihydro-1H-inden-5-yl)-1,2,4-oxadiazol-3-amine | C11H11N3O | 1340362-30-2 | Details |
| 1-Bromo-3,3,4,4,4-Pentafluoro-2-Butanone | C4H2BrF5O | 92737-01-4 | Details |
| Timolumab | 1073538-99-4 | Details |
| Tricine | C6H13NO5 | 5704-04-1 | Details |
| 2'-Cytidylic acid | C9H14N3O8P | 85-94-9 | Details |
| rac-tert-Butyl N-[(1R,3S)-3-(aminomethyl)cyclohexyl]carbamate | C12H24N2O2 | 347186-41-8 | Details |
| H-VYKYGGYNE-OH | Details |
| tert-Butyl N-methyl-N-[(2-methyloxiran-2-yl)methyl]carbamate | C10H19NO3 | 1251047-31-0 | Details |
| H-HCIRNKSVI-OH | Details |
| Val-Ile-Leu | Details |
| 4-Amino-1-phenylcyclohexan-1-ol | C12H17NO | 1461708-75-7 | Details |
| IsoE super | C16H26O | 54464-57-2 | Details |
| 1-(2,4-Dichlorophenyl)-2-methoxyethan-1-ol | C9H10Cl2O2 | 1514244-63-3 | Details |
| 20-Dehydro cholesterol 3-acetate | C29H46O2 | 54548-85-5 | Details |
| 6X His tag Antibody | Details |
| AG 126 | C10H5N3O3 | 118409-62-4 | Details |
| Ethyl 4-((3-(trifluoromethoxy)phenyl)amino)-3,5-thiazolecarboxylate | C13H11F3N2O3S | 1797782-21-8 | Details |
| N-[4-(4-Bromophenyl)-1,3-thiazol-2-yl]-2-chloro-N-(oxolan-2-ylmethyl)acetamide | C16H16BrClN2O2S | 735322-63-1 | Details |
| 1-Methyl-1H-indazole-3-carbohydrazide | C9H10N4O | 90558-67-1 | Details |
| 1,4-Dioxa-spiro[4.5]dec-8-yl methanesulfonate | C9H16O5S | 141120-33-4 | Details |
| 2-Propylfuran-3-carboxylic acid | C8H10O3 | 35768-35-5 | Details |
| Usaramine | C18H25NO6 | 15503-87-4 | Details |
| tert-Butyl N-(2-methyl-1,3-oxazol-4-yl)carbamate | C9H14N2O3 | 1240621-19-5 | Details |
| 1-(5-Aminopyridin-2-yl)-1,4-dihydropyridin-4-one | C10H9N3O | 1461715-13-8 | Details |
| [3-(Prop-2-en-1-yl)phenyl]methanol | C10H12O | 106965-54-2 | Details |
| Iodoaceticacid | C2H3IO2 | 64-69-7 | Details |
| Enolase 3 Blocking Peptide | Details |
| [1-(2,2,2-Trifluoroethyl)-1H-imidazol-5-yl]methanol | C6H7F3N2O | 1488678-34-7 | Details |
| H-FVTLVFR^-OH | Details |
| Methyl 2-(chlorosulfonyl)-4-fluorobenzoate | C8H6ClFO4S | 1156254-63-5 | Details |
| (S)-2-ureidopropanoic acid | C4H8N2O3 | 18409-49-9 | Details |
| 2-Bromo-2'-chloropropiophenone | C9H8BrClO | 75815-22-4 | Details |
| Methyl 5-(mercaptomethyl)furan-2-carboxylate | C7H8O3S | 859303-93-8 | Details |
| CARD6 antibody | Details |
| Fluorescein-5-thiosemicarbazide hydrochloride | C21H15N3O5S | 76863-28-0 | Details |
| tert-Butyl N-[(4,6-dimethylpiperidin-3-yl)methyl]carbamate hydrochloride | C13H27ClN2O2 | 1909313-44-5 | Details |
| 2-(1-Methyl-1H-pyrazol-3-yl)-1,3-thiazole-4-carbonitrile | C8H6N4S | 2044713-84-8 | Details |
| 3-(2-Methoxyethyl)piperidine hydrochloride | C8H17NO | 946715-83-9 | Details |
| (1-Methanesulfonylcyclopentyl)methanamine hydrochloride | C7H16ClNO2S | 1803567-26-1 | Details |
| Human Galectin 7 ELISA kit | Details |
| 2-Chloro-N-(2-chloro-4-methylphenyl)propanamide | C10H11Cl2NO | 1040079-49-9 | Details |
| 2,4-Di(tert-amyl)phenoxyacetic acid | C18H28O3 | 13402-96-5 | Details |
| 2-((4-chlorophenyl)sulfonyl)-N-(((phenylamino)thioxomethyl)amino)ethanamide | C15H14ClN3O3S2 | 1023568-82-2 | Details |
| tert-Butyl N-(1-benzofuran-2-yl)carbamate | C13H15NO3 | 1629535-19-8 | Details |
| H-AVIQHFQEK-OH | Details |
| Morpholine-13C4 | C4H9NO | 1217024-56-0 | Details |
| 2-(2-Aminoethoxy)-3-chloropyridine hydrochloride | C7H10Cl2N2O | 1394040-72-2 | Details |
| 4-Bromo-1-[(2-chlorophenyl)methyl]-1H-pyrazol-3-amine | C10H9BrClN3 | 925147-38-2 | Details |
| HIV1 rev protein | C97H173N51O24 | 141237-50-5 | Details |
| 4-(Pyrrolidin-1-yl)benzene-1-carboximidamide hydrochloride | C11H15N3.HCl | 1258650-14-4 | Details |
| 1,2,3-Tri-O-benzyl-4,6-O-benzylidene-a-D-mannopyranose | C34H34O6 | 57783-75-2 | Details |
| 4-[(Ethanesulfonyl)methyl]piperidine hydrochloride | C8H18ClNO2S | 1864064-64-1 | Details |
| ethyl 3-(4-((4'-nitrobenzyloxy)phenyl)prop-2-enoate-2-nitrile | C19H16N2O5 | 340212-06-8 | Details |
| 3-Amino-2,4-dichlorobenzoic acid | C7H5Cl2NO2 | 50917-28-7 | Details |
| 3-(6-Oxo-1,6-dihydropyridin-3-yl)propanoic acid hydrobromide | C8H10BrNO3 | 1795288-19-5 | Details |
| Allyl 2,3-O-isopropylidene-a-L-rhamnopyranoside | C12H20O5 | 71695-57-3 | Details |
| LCOR Blocking Peptide | Details |
| 1-[3-(Hydroxymethyl)phenyl]ethan-1-one | C9H10O2 | 125604-06-0 | Details |
| 8-Hydroxy loxapine | C18H18ClN3O2 | 61443-77-4 | Details |
| 1-[(1-Methyl-1H-pyrazol-4-yl)sulfonyl]piperazine hydrochloride | C8H15ClN4O2S | 1573547-65-5 | Details |
| 3-(4-Aminophenyl)phenol | C12H11NO | 779341-20-7 | Details |
| 1-[(4-Bromophenyl)methyl]-1H-pyrazole | C10H9BrN2 | 1159826-63-7 | Details |
| SURF4 Blocking Peptide | Details |
| CD11c antibody | Details |
| 1-[(tert-Butoxy)carbonyl]-1,2,3,6-tetrahydropyridine-3-carboxylic acid | C11H17NO4 | 86447-14-5 | Details |
| Cystatin-C monoclonal antibody | Details |
| 2-(Phenoxymethyl)aniline | C13H13NO | 78584-41-5 | Details |
| H-YKAAVDLSHFLKEKG-OH | Details |
| Azetidine-3-sulfonamide hydrochloride | C3H9ClN2O2S | 1909318-76-8 | Details |
| (2-Bromo-6-ethoxy-4-formylphenoxy)acetonitrile | C11H10BrNO3 | 832674-63-2 | Details |
| D-Ribopyranosyl amine | C5H11NO4 | 43179-09-5 | Details |
| N-(4-Bromopyridin-2-yl)cyclopropanecarboxamide | C9H9BrN2O | 1529768-99-7 | Details |
| 2-[Methyl[(tridecafluorohexyl)sulphonyl]amino]ethyl acrylate | C12H10F13NO4S | 67584-57-0 | Details |
| Rat anti Mouse IgG1 Kappa Light Chain | Details |
| 4-(Chloromethyl)-N,N-dimethylpyridin-2-amine hydrochloride | C8H12Cl2N2 | 1443981-52-9 | Details |
| 1-(1-Methyl-1H-pyrazol-5-yl)cyclopropane-1-carboxylic acid | C8H10N2O2 | 1536176-36-9 | Details |
| 2-(4-{[(tert-Butoxy)carbonyl]amino}oxolan-3-yl)acetic acid | C11H19NO5 | 1784684-42-9 | Details |
| 1',3'-Dihydrospiro[cyclobutane-1,2'-inden]-3'-one | C12H12O | 495414-28-3 | Details |
| 1-Methyl-N-[(4-methylphenyl)methyl]piperidin-4-amine | C14H22N2 | 359878-18-5 | Details |
| 2-Amino-1-(2,4-difluorophenyl)propan-1-one hydrochloride | C9H10ClF2NO | 2243521-41-5 | Details |
| 2-Chloro-5-(2-chlorophenyl)-1,3,4-thiadiazole | C8H4Cl2N2S | 36894-93-6 | Details |
| Toxoplasma gondii IgA ELISA kit | Details |
| 1,2-Bis(triethoxysilyl)acetylene | C14H30O6Si2 | 17947-91-0 | Details |
| 4-(Isobutylamino)-2-(Methylthio)Pyrimidine-5-Carboxylic Acid | C10H15N3O2S | 1015856-38-8 | Details |
| AF594 Donkey anti Goat IgG (H + L) (Fab 2) | Details |
| Cariprazine-d6 | C21H32Cl2N4O | 1308278-67-2 | Details |
| 3-(4-(dimethylamino)phenyl)-2-(phenylsulfonyl)prop-2-enenitrile | C17H16N2O2S | 141692-09-3 | Details |
| HSV1 + HSV2 antibody (FITC) | Details |
| Cullin 5 Blocking Peptide | Details |
| 3-(1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}piperidin-3-yl)prop-2-ynoic acid | C23H21NO4 | 2138033-46-0 | Details |
| 2-Methylthioadenosine | C11H15N5O4S | 4105-39-9 | Details |
| Product Total： Product Page： | ||||
| 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 | ||||